Ptc Therapeutics (PTCT) Interest & Investment Income (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Interest & Investment Income of -$49.0 million in Q1 2026, up 11.16% quarter-over-quarter from -$55.2 million in Q4 2025, and down 43.82% on a YoY basis from -$87.3 million in Q1 2025.
Ptc Therapeutics (PTCT) Interest & Investment Income (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Interest & Investment Income history runs 15 years deep, the most recent figure standing at -$49.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 43.82% year-over-year to -$49.0 million; the TTM figure through Mar 2026 stood at -$167.2 million (down 4.32% YoY), while the FY2025 annual figure was -$152.2 million, up 8.84% from the prior year.
- Interest & Investment Income was -$49.0 million for Q1 2026 at Ptc Therapeutics, up from -$55.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$20.9 million in Q3 2022 to a low of -$55.2 million in Q4 2025.
- Historically, Interest & Investment Income has averaged -$34.6 million across 5 years, with a median of -$32.6 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income sank 80.71% in 2023, then jumped 30.2% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at -$24.5 million in 2022, then tumbled by 80.71% to -$44.3 million in 2023, then advanced by 7.26% to -$41.1 million in 2024, then sank by 34.41% to -$55.2 million in 2025, then climbed by 11.16% to -$49.0 million in 2026.
- The last three Interest & Investment Income figures came in at -$49.0 million (Q1 2026), -$55.2 million (Q4 2025), and -$32.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -49.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.03 Mn |
| Dec 31, 2025 | -55.19 Mn |
| Sep 30, 2025 | -32.59 Mn |
| Jun 30, 2025 | -30.36 Mn |
| Mar 31, 2025 | -34.09 Mn |
| Dec 31, 2024 | -41.06 Mn |
| Sep 30, 2024 | -41.61 Mn |
| Jun 30, 2024 | -43.49 Mn |
| Mar 31, 2024 | -40.83 Mn |
| Dec 31, 2023 | -44.28 Mn |
| Sep 30, 2023 | -28.16 Mn |
| Jun 30, 2023 | -29.42 Mn |
| Mar 31, 2023 | -27.33 Mn |
| Dec 31, 2022 | -24.50 Mn |
| Sep 30, 2022 | -20.88 Mn |
| Jun 30, 2022 | -21.98 Mn |
| Mar 31, 2022 | -23.51 Mn |
| Dec 31, 2021 | -22.50 Mn |
| Sep 30, 2021 | -21.80 Mn |
| Jun 30, 2021 | -22.56 Mn |